Literature DB >> 2560099

Further analysis of the disturbed adrenocortical function in the cerebro-hepato-renal syndrome of Zellweger.

L Govaerts1, W G Sippell, L Monnens.   

Abstract

Plasma aldosterone, corticosterone, 11-deoxycorticosterone, progesterone, 17-hydroxyprogesterone, 11-desoxycortisol, cortisol and cortisone were determined simultaneously in small plasma samples obtained during an i.v. ACTH (Synacthen) stimulation test in five patients (age 4-7 years) with Zellweger syndrome. The response of all ACTH-dependent steroids to Synacthen was severely impaired in all patients, despite normal basal levels. It can be concluded that the biochemical defect in adrenal steroidogenesis causing the inadequate response to ACTH injection is located proximal to progesterone. We propose that the lack of responsiveness to ACTH is secondary to an abnormality of ACTH receptors on the adrenocortical cell. The extremely low levels of non-specific lipid transfer protein may be a contributing factor.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2560099     DOI: 10.1007/BF01802037

Source DB:  PubMed          Journal:  J Inherit Metab Dis        ISSN: 0141-8955            Impact factor:   4.982


  28 in total

1.  Infantile Refsum's disease: biochemical findings suggesting multiple peroxisomal dysfunction.

Authors:  B T Poll-The; J M Saudubray; H Ogier; R B Schutgens; R J Wanders; G Schrakamp; H van den Bosch; J M Trijbels; A Poulos; H W Moser
Journal:  J Inherit Metab Dis       Date:  1986       Impact factor: 4.982

2.  Disturbed adrenocortical function in cerebro-hepato-renal syndrome of Zellweger.

Authors:  L Govaerts; L Monnens; T Melis; F Trijbels
Journal:  Eur J Pediatr       Date:  1984-11       Impact factor: 3.183

3.  Cerebro-hepato-renal (Zellweger) syndrome and neonatal adrenoleukodystrophy: similarities in phenotype and accumulation of very long chain fatty acids.

Authors:  F R Brown; A J McAdams; J W Cummins; R Konkol; I Singh; A B Moser; H W Moser
Journal:  Johns Hopkins Med J       Date:  1982-12

4.  Biochemical studies in the liver and muscle of patients with Zellweger syndrome.

Authors:  J M Trijbels; J A Berden; L A Monnens; J L Willems; A J Janssen; R B Schutgens; M van den Broek-Van Essen
Journal:  Pediatr Res       Date:  1983-06       Impact factor: 3.756

5.  Deficiency of acyl-CoA: dihydroxyacetone phosphate acyltransferase in patients with Zellweger (cerebro-hepato-renal) syndrome.

Authors:  R B Schutgens; G J Romeyn; R J Wanders; H van den Bosch; G Schrakamp; H S Heymans
Journal:  Biochem Biophys Res Commun       Date:  1984-04-16       Impact factor: 3.575

6.  Deficiency of plasmalogens in the cerebro-hepato-renal (Zellweger) syndrome.

Authors:  H S Heymans; H vd Bosch; R B Schutgens; W H Tegelaers; J U Walther; J Müller-Höcker; P Borst
Journal:  Eur J Pediatr       Date:  1984-04       Impact factor: 3.183

7.  Serum very long chain fatty acid pattern in Zellweger syndrome.

Authors:  J A Bakkeren; L A Monnens; J M Trijbels; J M Maas
Journal:  Clin Chim Acta       Date:  1984-04-27       Impact factor: 3.786

8.  Hyperpipecolic acidemia in neonatal adrenoleukodystrophy.

Authors:  R I Kelley; H W Moser
Journal:  Am J Med Genet       Date:  1984-12

9.  Adrenoleukodystrophy: increased plasma content of saturated very long chain fatty acids.

Authors:  H W Moser; A B Moser; K K Frayer; W Chen; J D Schulman; B P O'Neill; Y Kishimoto
Journal:  Neurology       Date:  1981-10       Impact factor: 9.910

10.  Peroxisomal defects in neonatal-onset and X-linked adrenoleukodystrophies.

Authors:  S Goldfischer; J Collins; I Rapin; B Coltoff-Schiller; C H Chang; M Nigro; V H Black; N B Javitt; H W Moser; P B Lazarow
Journal:  Science       Date:  1985-01-04       Impact factor: 47.728

View more
  1 in total

1.  High prevalence of primary adrenal insufficiency in Zellweger spectrum disorders.

Authors:  Kevin Berendse; Marc Engelen; Gabor E Linthorst; A S Paul van Trotsenburg; Bwee Tien Poll-The
Journal:  Orphanet J Rare Dis       Date:  2014-09-02       Impact factor: 4.123

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.